Antithrombotic formulation, process for its manufacturing, and use thereof

摘要

PCT No. PCT/SE95/01425 Sec. 371 Date Dec. 18, 1995 Sec. 102(e) Date Dec. 18, 1995 PCT Filed Nov. 29, 1995 PCT Pub. No. WO96/16671 PCT Pub. Date Jun. 6, 1996A new pharmaceutical formulation comprising the thrombin inhibitor HOOC-CH2-(R)-Cgl-Aze-Pab in combination with one or more absorption enhancing agents, a process for the preparation of such a pharmacutical formulation, the use of such a formulation in the treatment of thromboembolism as well as a method of treating a patient in need of antithrombotic treatment and thromboembolism by using said formulation.